speb/financial-data huggingface dataset:
TRIGYN.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 8060565000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Current Assets: 6822811000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 9400000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Current Debt: 0.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 9400000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Current Deferred Assets: 243393000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 1603182000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 304824000.00
TRIGYN.NS cash_flow (annual, 2024-03-31) — Depreciation: 36840000.00
TRIGYN.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 68768000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 68769000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 36841000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 30786000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Diluted EPS: 6.48
TRIGYN.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 199633000.00
TRIGYN.NS cash_flow (annual, 2024-03-31) — Dividends Received Cfi: 71759000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — EBIT: 391979000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — EBITDA: 460748000.00
TRIGYN.NS cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 75706000.00
TRIGYN.NS cash_flow (annual, 2024-03-31) — End Cash Position: 3361781000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 97097000.00
TRIGYN.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -37417000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 75657000.00
TRIGYN.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 1252052000.00
TRIGYN.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -71759000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 3424921000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Goodwill: 867433000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 950088000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 3047406000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 243712000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Gross Profit: 4736058000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Interest Expense: 9873000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 9873000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Interest Income: 47337000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 47337000.00
TRIGYN.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -16571000.00
TRIGYN.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 47337000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Inventory: 75657000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 7012135000.00
TRIGYN.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: 682981000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 236379000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 37580000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 0.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 37580000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 84016000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 147037000.00
TRIGYN.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: 16870000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Net Income: 199633000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 199633000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 199633000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Net Income Extraordinary: 0.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 199633000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 199633000.00
TRIGYN.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 382106000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 199633000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Net Interest Income: 30767000.00
TRIGYN.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 571428000.00
TRIGYN.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -20846000.00
TRIGYN.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -20846000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: 30767000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Net PPE: 75125000.00
TRIGYN.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -7543000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 6062047000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 125947000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 84016000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 130499000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 460748000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Normalized Income: 199633000.00
TRIGYN.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 1259595000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Operating Income: 295615000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Operating Revenue: 12796623000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 30785736.00
TRIGYN.NS cash_flow (annual, 2024-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 358111000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 1000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 1000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 82655000.00
TRIGYN.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: -30766000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 1000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: -1000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 834000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 812474000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Other Payable: 399255000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Other Properties: 62531000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 467244000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 467244000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Payables: 1199485000.00
TRIGYN.NS cash_flow (annual, 2024-03-31) — Pension And Employee Benefit Expense: -3592000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 88553000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 183261000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Pretax Income: 382106000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
TRIGYN.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 443059000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 8060565000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 68768000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 9738000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 9738000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 4191580000.00
TRIGYN.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 571428000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 1789000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 3426710000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Share Issued: 30785736.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Special Income Charges: 0.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 7012135000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 6062047000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 0.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Tax Provision: 182473000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.30
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 687000.00
TRIGYN.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -273813000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Total Assets: 8736912000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 7012135000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Total Debt: 46980000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 7012135000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Total Expenses: 12501008000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 1724777000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 1914101000.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 121595000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 6697000.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 0.00
TRIGYN.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 0.00
TRIGYN.NS balance_sheet (annual, 2024-03-31) — Working Capital: 5219629000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 660725000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 2315050000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 666914000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 41219000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 307857000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 3461907000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 3767768000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 307857000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 7120897000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 0.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 6699302000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 6911000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 297000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 7208000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 1338694000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 88358000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Goodwill: 867433000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 926678000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 60577000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 98240000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 7121194000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 666914000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 34308000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 0.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 34308000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Long Term Provisions: 95764000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 60577000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 6194219000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 85814000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 30785736.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 417469000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 50058000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 6813040000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Other Intangible Assets: 59245000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 57574000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: 1000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 60577000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 305861000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Payables: 660725000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 30785736.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 7120897000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 6194219000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 100775000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 8589664000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 7120897000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 41516000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 7120897000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 1468767000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 1890361000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 130073000.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 0.00
TRIGYN.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 5360608000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — +Operating Expense: 3999691000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 1124374000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — +Total Revenue: 8977908000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 2404736000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 699743000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 699743000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 2436592000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 2436592000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -196696000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -196696000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 1393771000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1393771000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -653367000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -653367000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Amortization: 22279000.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 22279000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 257509000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 257509000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 30809948.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 30816867.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Basic EPS: 3.82
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 0.83
TRIGYN.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 3361781000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 34144000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 34144000.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -1269000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 38734000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 38734000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 307857000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 307857000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 4130622000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 4130622000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 4130622000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 4130622000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 2910847000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 2910847000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 1219775000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 1219775000.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -12939000.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 6164000.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — Change In Payable: -100487000.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — Change In Receivables: 510797000.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: 403535000.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 637849000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Common Stock: 307857000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 307857000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 7410564000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 7410564000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 0.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 0.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 4835171000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1236881000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Current Assets: 7202713000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 7202713000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 8346000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 8346000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Current Debt: 88863000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 88863000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 97209000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 97209000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Current Deferred Assets: 198414000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Assets: 198414000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 1495884000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1495884000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 271478000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 271478000.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — Depreciation: 50098000.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 50098000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 50098000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 12436000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 50098000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 12436000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 30809948.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 30816867.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Diluted EPS: 3.82
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.83
TRIGYN.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 117694000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 25578000.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 114086000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — EBIT: 308657000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — EBIT: 86198000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — EBITDA: 358755000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — EBITDA: 98634000.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 130991000.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — End Cash Position: 4130622000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 127121000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 127121000.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -34555000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 88381000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 88381000.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 513656000.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -102302000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 3586179000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Goodwill: 867433000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 867433000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 916036000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 916036000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 3089959000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 3089959000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 246255000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 246255000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Gross Profit: 4142737000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 1167855000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Interest Expense: 27720000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 18815000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 27720000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 18815000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Interest Income: 63063000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 63063000.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -27759000.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 63063000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Inventory: 88381000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 88381000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 7499427000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 7499427000.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: 157479000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 384630000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 384630000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 30388000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 30388000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 0.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 0.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 30388000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 30388000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 97386000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 97386000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 148469000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 148469000.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 21876000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Net Income: 117694000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Net Income: 25578000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 117694000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 25578000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 134759000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 29460000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Net Income Discontinuous Operations: -17063000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: -3882000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Net Income Extraordinary: 11784000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 117694000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 25578000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 134757000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 29460000.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 264664000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 117696000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 25578000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Net Interest Income: -27720000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -18815000.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -18401000.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -6796000.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -6796000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -27720000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -18815000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Net PPE: 49559000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 49559000.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -1269000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 6494528000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 6494528000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 45219000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 45219000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 97386000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 97386000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 151154000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 151154000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 370539000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 98634000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Normalized Income: 143005800.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 29460000.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 514925000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Operating Income: 143046000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Operating Income: 43481000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Operating Revenue: 8977908000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 2404736000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 30785736.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 30785736.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: -1000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: -1000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 1000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 1000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 4000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 4000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 48603000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 48603000.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: -35088000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 57587000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 57587000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 177394000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 42716000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 3949593000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 1111938000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Other Payable: 319243000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 319243000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Other Properties: 63642000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 63642000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 103045000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 103045000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 103045000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 103045000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Payables: 1018986000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Payables: 1018986000.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — Pension And Employee Benefit Expense: -2501000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 108209000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 108209000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 244690000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 244690000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Pretax Income: 280937000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 67383000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -18401000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 4835171000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1236881000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 50098000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 12436000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 11496000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 11496000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 4306157000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 4306157000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 1683000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 3587862000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Share Issued: 30785736.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 30785736.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Special Income Charges: -11784000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 7410564000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 7410564000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 6494528000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 6494528000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: -3535200.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Tax Provision: 146178000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 37923000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.30
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.30
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 970000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 970000.00
TRIGYN.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -194532000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Total Assets: 9034222000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 9034222000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 7410564000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 7410564000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Total Debt: 127597000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 127597000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 7410564000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 7410564000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Total Expenses: 8834862000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 2361255000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 1623658000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1623658000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 1831509000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 1831509000.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 127774000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 127774000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 16891000.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Total Unusual Items: -11784000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
TRIGYN.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -11784000.00
TRIGYN.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
TRIGYN.NS balance_sheet (annual, 2025-03-31) — Working Capital: 5706829000.00
TRIGYN.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 5706829000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 1071792000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 2244999000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 30724000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Basic EPS: -1.50
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1205086000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 7753000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 7753000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 30724000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: -1.50
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -46086000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — EBIT: 12521000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — EBITDA: 20274000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 1039913000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 5356000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 5356000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Net Income: -46086000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -46086000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -44498000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Net Income Discontinuous Operations: -1588000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -46086000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -44498000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -46086000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -5356000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -5356000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 20274000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Normalized Income: -44498000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Operating Income: -31879000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 2244999000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 44401000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 1064039000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 7165000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1205086000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 7753000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 51663000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.30
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 2276878000.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
TRIGYN.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 1169056000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 2419514000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 812287000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 2665687000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Assets Held For Sale Current: 11805000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 666648000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 30830994.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 1.71
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 37247000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 307857000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 3817296000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 4127632000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 307857000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 7615276000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1237142000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 7327460000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 7687000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 30172000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 37859000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 1396421000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 120007000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 8622000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 8622000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 30830994.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.71
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 52721000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — EBIT: 54077000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — EBITDA: 62699000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Goodwill: 867433000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 910420000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 48609000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 1182372000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 6297000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 6297000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 88466000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 7645448000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 666648000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 29560000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 29560000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 120513000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Net Income: 52721000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 52721000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 53025000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Net Income Discontinuous Operations: -304000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 52721000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 53025000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 52721000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -6297000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -6297000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 48609000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 6704856000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 64762000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 62699000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 53025000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Operating Income: 13316000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 2419514000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 30785736.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 317549000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 9194000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 7307419000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 42987000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 57649000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 40761000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 1160434000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 48609000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 310336000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Payables: 812287000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 47780000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1237142000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 8622000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 30785736.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 7615276000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 6704856000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Tax Provision: -5245000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.30
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 116321000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 9161770000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 7615276000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 67419000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 7615276000.00
TRIGYN.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 2406198000.00
TRIGYN.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1546494000.00